OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
Mike Hennessy Jr. is the President and CEO of MJH Life Sciences.
March 02, 2023
That wave beginning to crash over PhRMA’s gunwales may well emanate from a startup mindset, rather than Big Pharma or government policy pundits.
February 02, 2023
The restraint to not target solely the major disease groups has provided good proportion and balance for our industry.
January 02, 2023
Cell and gene therapies is unequivocally viewed as the biggest opportunity in the bio/pharma space.
December 02, 2022
Science news can be just so weird, or weirdly useful, that everything else recedes as we ponder whether it is true and what consequences it might bring.
November 02, 2022
Next year's "FDA Voices" series will cover core topics FDA staff are prioritizing.
October 02, 2022
The 1VQ papers advocate for the idea that certain post-approval changes should be streamlined and expedited.